Keimyung University: Researchers Explore FDM 3D Printing in Feasibility of Manufacturing 3D Printed Medications https://ift.tt/2GWsVSE Researchers from Keimyung University have published a recent article exploring how new processes may change the realm of pharmaceuticals in ‘Complex formulations, simple techniques: Can 3D printing technology be the Midas touch in pharmaceutical industry?’ The authors are well aware of the typical benefits of 3D printing such as affordability, speed in production, and the potential for cutting out labor and on-site factory expenses; however, the benefits in pharmaceuticals extend far beyond the basics due to the ability to make medications that are personalized, with patient-specific dosages that could be made in a variety of different forms—and released into the body at varying levels of intensity. The researchers address varying types of 3D printing technology being used currently in pharmaceuticals, and their focus for the study at hand:
FDM 3D printing has been known for challenges in loading drugs into different types of filament, along with releasing of medications, but the scientists are still optimistic:
Some of the promise behind FDM 3D printing in pharmaceuticals may be due to the amount of accuracy and versatility available, along with the ability for users to employ multiple nozzles. The researchers state that this is a major break-through with the possibility of making variations such as coated tablets that would require dual nozzle capability. Previously, variety in shapes and forms of tablets has caused erratic performance in drug delivery, along with the issue of APIs as one of the major stumbling blocks due to chemical incompatibility.
It is also hoped that 3D printing may be able to precipitate greater usage of capsules in patient-specific medications, due to the possibility of offering a single-step process. A process has also been created for making liquid medications via FDM 3D printing with a syringe nozzle. Another method in FDM 3D printing was tested using ibuprofen for ‘sustained release,’ along with other tablets made of predesigned scaffold structures. Fast-dissolving film (FDF) medications show promise too.
3D printing and its impacts on the medical field have been felt far and wide in the most positive and progressive ways possible—even allowing for new implants, devices, and modelsto be created that may not have been possible before, along with incredible potential spilling over into the drug and pharmaceutical industries. As we see repeated research into 3D printed medications and become more convinced of the relative ease in which they could be produced, the reality of this technology transforming pharmaceuticals seems imminent; however, obvious challenges must be overcome to make such processes truly feasible, along with considerably more development. What do you think of this news? Let us know your thoughts! Join the discussion of this and other 3D printing topics at 3DPrintBoard.com. [Source / Images: Complex formulations, simple techniques: Can 3D printing technology be the Midas touch in pharmaceutical industry?]
Printing via 3DPrint.com | The Voice of 3D Printing / Additive Manufacturing https://3dprint.com February 21, 2019 at 12:48PM
0 Comments
Leave a Reply. |
Categories
All
Archives
April 2023
|